Detalhe da pesquisa
1.
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.
Immunity
; 49(1): 178-193.e7, 2018 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29958801
2.
An open protocol for modeling T Cell Clonotype repertoires using TCRß CDR3 sequences.
BMC Genomics
; 24(1): 349, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365517
3.
Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity.
Proc Natl Acad Sci U S A
; 117(14): 8022-8031, 2020 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213589
4.
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.
Lancet Oncol
; 22(1): 118-131, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387490
5.
CSF-1R-Dependent Lethal Hepatotoxicity When Agonistic CD40 Antibody Is Given before but Not after Chemotherapy.
J Immunol
; 197(1): 179-87, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27217585
6.
Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.
J Immunol
; 192(4): 1433-9, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24403535
7.
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.
J Immunol
; 190(1): 469-78, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225891
8.
Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer.
Cancer Immunol Res
; 12(5): 544-558, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381401
9.
An open protocol for modeling T Cell Clonotype repertoires using TCRß CDR3 sequences.
Res Sq
; 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824803
10.
Machine learning links T cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer.
bioRxiv
; 2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961410
11.
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Nat Med
; 28(6): 1167-1177, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35662283
12.
Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
Kidney Int
; 79(4): 452-63, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20980973
13.
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40.
Nat Commun
; 12(1): 3424, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103524
14.
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Clin Cancer Res
; 27(16): 4574-4586, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112709
15.
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.
Sci Transl Med
; 13(594)2021 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011631
16.
Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice.
J Immunol
; 181(10): 7367-79, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981160
17.
Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.
J Am Soc Nephrol
; 20(12): 2581-92, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19926892
18.
Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes.
Front Immunol
; 11: 629722, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597954
19.
CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity.
JCI Insight
; 5(10)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32324594
20.
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma.
J Vis Exp
; (153)2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31814615